Tranzactioneaza Sutro Biopharma Inc (US.STRO) - 3.72 USD (%) Tranzactioneaza
Indici
Descriere companie
Sutro Biopharma, Inc. (http://www.sutrobio.com/) is a clinical stage drug discovery, development and manufacturing company. It is focused on deploying its integrated cell-free protein synthesis platform, XpressCF, to create a variety of protein therapeutics, for cancer and autoimmune disorders. It is engaged in designing therapeutics using potent modalities, including cytokine-based therapeutics, immuno-oncology (I/O) agents, antibody-drug conjugates (ADCs) and bispecific antibodies that are directed primarily against clinically validated targets. Its product candidate includes STRO-001 and STRO-002. STRO-001, is an ADC directed against the cancer target CD74, for patients with multiple myeloma and non-Hodgkin lymphoma (NHL). STRO-002, is an ADC directed against folate receptor-alpha (FolRa), for patients with ovarian and endometrial cancers. STRO-001 and STRO-002 are designed and optimized for therapeutic index by placing linker-warheads at specific locations within the antibody.